Gastric lymphoma: Difference between revisions
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Primary | Primary gastric lymphoma is [[Cancer (disease)|cancer]] [[derived]] from [[lymphocytes]] (a type of [[White blood cells|white blood cell]]) that originates in the [[stomach]]<ref>Dawson IMP, Cornes JS, Morrison BC. Primary malignant lymphoid tumours of the intestinal tract. Br J Surg. 1961;49:80-89.</ref> | ||
Most common cause of primary gastric lymphoma is mucosa-associated lymphoid tissue (MALT) | Most common cause of primary gastric lymphoma is [[Mucosa-associated lymphoid tissue (MALT) lymphoma|mucosa-associated lymphoid tissue (MALT)]] [[lymphoma]] and [[Diffuse large B-cell lymphoma|diffuse large B-cell lymphoma (DLBCL)]] of the [[stomach]]. These account for 90% of all [[Diagnosis|diagnosed]] cases. [[Lymphomas]] originating outside the [[lymph nodes]] are referred to as [[Lymphoma|extra nodal lymphoma]]. Primary gastric lymphoma is the most common type of [[Lymphoma|extra nodal lymphoma]]. | ||
Primary gastric Lymphoma is a rare condition.<ref>Aisenberg AC. Coherent view of non-Hodgkin's lymphoma. J Clin Oncol. 1995;13:2656-2675.</ref> Gastric lymphoma accounts for less than 15% of gastric malignancies and about 2% of all lymphomas. Most of the primary gastric lymphomas are B cell non-Hodgkin lymphoma(NHL) . | Primary gastric Lymphoma is a [[rare]] condition.<ref>Aisenberg AC. Coherent view of non-Hodgkin's lymphoma. J Clin Oncol. 1995;13:2656-2675.</ref> Gastric lymphoma accounts for less than 15% of [[Gastric malignancy|gastric malignancies]] and about 2% of all [[lymphomas]]. Most of the primary gastric lymphomas are [[B cell]] [[Non-Hodgkin lymphoma|non-Hodgkin lymphoma(NHL)]]. | ||
==Primary Gastric Lymphoma== | ==Primary Gastric Lymphoma== |
Revision as of 19:28, 8 January 2018
WikiDoc Resources for Gastric lymphoma |
Articles |
---|
Most recent articles on Gastric lymphoma Most cited articles on Gastric lymphoma |
Media |
Powerpoint slides on Gastric lymphoma |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Gastric lymphoma at Clinical Trials.gov Trial results on Gastric lymphoma Clinical Trials on Gastric lymphoma at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Gastric lymphoma NICE Guidance on Gastric lymphoma
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Gastric lymphoma Discussion groups on Gastric lymphoma Patient Handouts on Gastric lymphoma Directions to Hospitals Treating Gastric lymphoma Risk calculators and risk factors for Gastric lymphoma
|
Healthcare Provider Resources |
Causes & Risk Factors for Gastric lymphoma |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Mazia Fatima, MBBS [2]
Overview
Primary gastric lymphoma is cancer derived from lymphocytes (a type of white blood cell) that originates in the stomach[1]
Most common cause of primary gastric lymphoma is mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma (DLBCL) of the stomach. These account for 90% of all diagnosed cases. Lymphomas originating outside the lymph nodes are referred to as extra nodal lymphoma. Primary gastric lymphoma is the most common type of extra nodal lymphoma.
Primary gastric Lymphoma is a rare condition.[2] Gastric lymphoma accounts for less than 15% of gastric malignancies and about 2% of all lymphomas. Most of the primary gastric lymphomas are B cell non-Hodgkin lymphoma(NHL).
Primary Gastric Lymphoma
Demographics
Primary gastric lymphoma commonly affects elderly patients in the fifth or sixth decade of life.[3] Primary gastric lymphoma is more prevalent in men than in women.
Clinical presentation
Symptoms
Common symptoms of primary gastric lymphoma include:
- Epigastric discomfort
- Anorexia
- Weight loss
- Nausea associated with or without vomiting
- Occult gastrointestinal bleeding
- Early satiety
Less common symptoms include :
- Fever
- Night sweats
Physical Examination
- Patients with primary gastric lymphoma usually appear normal.
- Physical examination of patients with primary gastric lymphoma is usually remarkable for palpable mass and peripheral lymphadenopathy.
Diagnosis
- Upper gastrointestinal endoscopy with biopsy is the gold standard test for the diagnosis of gastric lymphoma.
- Laparotomy and laparoscopy should be performed when the patient presents with complications such as perforation or obstruction.
- Findings on upper gastrointestinal endoscopy suggestive of gastric lymphoma:
- Mucosal erythema
- A mass or polypoid lesion with or without ulceration
- Benign-appearing gastric ulcer
- Nodular lesion
- Thickened, cerebroid gastric folds
An endoscopic ultrasound (EUS) will help assess the depth of lymphoma invasion and involvement of perigastric nodes. MALT lymphoma presents as superficial spreading or diffuse infiltrating lesion whereas diffuse large B cell lymphoma has a typical mass forming lesion appearance on endoscopic ultrasound. Imaging investigations including CT scans or endoscopic ultrasound are useful to stage disease. Hematological parameters are usually checked to assist with staging and to exclude concomitant leukemia. An elevated LDH level may be suggestive of lymphoma.
Histopathology
Most of the gastric lymphomas are predominantly non-Hodgkin’s lymphoma of B-cell origin. Primary gastric lymphoma can vary from being well-differentiated, low-grade lymphomas to high grade or large cell lymphomas.
Risk Factors
Risk factors for gastric lymphoma include the following:[4]
- Helicobacter pylori
- Long-term immunosuppressant drug therapy
- HIV infection
Differential Diagnosis
Gastric lymphoma must be differentiated from conditions with similar presentation like acute gastritis, chronic gastritis, atrophic gastritis, Crohn's disease, gastroesophageal reflux disease, peptic ulcer disease, gastrinoma and gastric adenocarcinoma :[5][6][7][8][9][10][11][12][13]
Disease | Cause | Symptoms | Diagnosis | Other findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pain | Nausea
& Vomiting |
Heartburn | Belching or
Bloating |
Weight loss | Loss of
Appetite |
Stools | Endoscopy findings | |||||
Location | Aggravating Factors | Alleviating Factors | ||||||||||
Primary gastric lymphoma |
|
- | - | - | - | - | ? | - | - | Useful in collecting the tissue for biopsy | Other symptoms
| |
Acute gastritis |
|
Food | Antacids | ? | ? | ? | - | ? | Black stools | - | ||
Chronic gastritis |
|
Food | Antacids | ? | ? | ? | ? | ? | - | H. pylori gastritis
Lymphocytic gastritis
|
- | |
Atrophic gastritis | Epigastric pain | - | - | ? | - | ? | ? | - | H. pylori
|
Autoimmune gastritis diagnosis include:
| ||
Crohn's disease | - | - | - | - | - | ? | ? |
|
|
|||
GERD |
|
|
|
?
(Suspect delayed gastric emptying) |
? | - | - | - | - |
|
Other symptoms:
Complications
| |
Peptic ulcer disease |
|
|
Duodenal ulcer
|
|
? | ? | - | - | - | Gastric ulcers
Duodenal ulcers
|
Other diagnostic tests | |
Gastrinoma |
|
- | - | ?
(suspect gastric outlet obstruction) |
? | - | - | - | Useful in collecting the tissue for biopsy |
Diagnostic tests
| ||
Gastric Adenocarcinoma |
|
- | - | ? | ? | ? | ? | ? |
|
Esophagogastroduodenoscopy
|
Other symptoms |
Treatment
- The predominant therapy for diffuse large B-cell lymphomas of the stomach is chemotherapy.
- Second line therapy for MALT lymphomas is usually chemotherapy with a single agent, and complete response rates of greater than 70% have been observed.
- Chemotherapy includes treatment with CHOP with or without rituximab.
- The mainstay of therapy for MALT lymphomas is antibiotic treatment to eradicate H.pylori. Regression is seen in about 60% of cases with eradication therapy alone.
- Single drug chemotherapy is recommended as a second line therapy for MALT lymphomas and is associated with a complete resolution of symptoms in greater than 70% cases.
- In case of complications like gastric outlet obstruction, the recommended treatment is subtotal gastrectomy followed by post-operative.
References
- ↑ Dawson IMP, Cornes JS, Morrison BC. Primary malignant lymphoid tumours of the intestinal tract. Br J Surg. 1961;49:80-89.
- ↑ Aisenberg AC. Coherent view of non-Hodgkin's lymphoma. J Clin Oncol. 1995;13:2656-2675.
- ↑ Thirlby RC. Gastrointestinal lymphoma: a surgical perspective. Oncology (Huntingt). 1993;7:29-32.
- ↑ NEJM article
- ↑ Sugimachi K, Inokuchi K, Kuwano H, Ooiwa T (1984). "Acute gastritis clinically classified in accordance with data from both upper GI series and endoscopy". Scand J Gastroenterol. 19 (1): 31–7. PMID 6710074.
- ↑ Sipponen P, Maaroos HI (2015). "Chronic gastritis". Scand J Gastroenterol. 50 (6): 657–67. doi:10.3109/00365521.2015.1019918. PMC 4673514. PMID 25901896.
- ↑ Sartor RB (2006). "Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis". Nat Clin Pract Gastroenterol Hepatol. 3 (7): 390–407. doi:10.1038/ncpgasthep0528. PMID 16819502.
- ↑ Sipponen P (1989). "Atrophic gastritis as a premalignant condition". Ann Med. 21 (4): 287–90. PMID 2789799.
- ↑ Badillo R, Francis D (2014). "Diagnosis and treatment of gastroesophageal reflux disease". World J Gastrointest Pharmacol Ther. 5 (3): 105–12. doi:10.4292/wjgpt.v5.i3.105. PMC 4133436. PMID 25133039.
- ↑ Ramakrishnan K, Salinas RC (2007). "Peptic ulcer disease". Am Fam Physician. 76 (7): 1005–12. PMID 17956071.
- ↑ Banasch M, Schmitz F (2007). "Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors". Wien Klin Wochenschr. 119 (19–20): 573–8. doi:10.1007/s00508-007-0884-2. PMID 17985090.
- ↑ Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM (2005). "Gastric adenocarcinoma: review and considerations for future directions". Ann Surg. 241 (1): 27–39. PMC 1356843. PMID 15621988.
- ↑ Ghimire P, Wu GY, Zhu L (2011). "Primary gastrointestinal lymphoma". World J Gastroenterol. 17 (6): 697–707. doi:10.3748/wjg.v17.i6.697. PMC 3042647. PMID 21390139.